Related Experiment Video

Updated: Jun 8, 2025

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

17.6K

Decoding the Promise and Challenges of miRNA-Based Cancer Therapies: An Essential Update on miR-21, miR-34, and

Hongbo Qian1, Mazaher Maghsoudloo2, Parham Jabbarzadeh Kaboli3

  • 1Shulan International Medical College, Zhejiang Shuren University, Hangzhou, Zhejiang, China.

International Journal of Medical Sciences
|November 8, 2024
PubMed

Insights

MicroRNA (miRNA)-based cancer therapies face challenges like delivery and side effects. This review examines specific miRNAs and advances in overcoming these hurdles for better cancer treatment outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biotechnology

Background:

  • MicroRNA (miRNA)-based therapies show promise for cancer treatment but face significant challenges.
  • Expression variability, off-target effects, and delivery issues have led to clinical trial failures.

Purpose of the Study:

  • To review the setbacks in miRNA-based cancer therapies, focusing on specific miRNAs (miR-21, miR-34, miR-155).
  • To highlight advances in overcoming delivery, efficacy, and complexity challenges in miRNA therapeutics.
  • To explore miRNA interactions with other non-coding RNAs (lncRNAs, circRNAs) in cancer.

Main Methods:

  • Literature review of miRNA-based cancer therapies.
  • Analysis of specific miRNA examples (miR-21, miR-34, miR-155) and their challenges.
  • Examination of recent advances in delivery systems, combination therapies, and personalized approaches.

Main Results:

  • Identified functional complexity and off-target effects as key hurdles for specific miRNAs.
  • Highlighted challenges in effective delivery of miRNA therapeutics.
  • Showcased progress in advanced delivery methods, combination strategies, and personalized medicine.

Conclusions:

  • Overcoming challenges in miRNA expression, delivery, and off-target effects is crucial for therapeutic success.
  • Understanding intricate miRNA interactions with other non-coding RNAs is vital for cancer biology.
  • Future research should focus on advanced strategies to harness miRNA potential for effective cancer therapy and improved patient outcomes.
Keywords:
cancer treatment.miR-155miR-21miR-34miRNA therapy

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.5K
Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.6K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.6K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K